Pacific Biosciences Of California (PACB) Revenue (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Revenue of $37.2 million for Q1 2026, little changed year-over-year from $37.2 million in Q1 2025, and down 16.73% quarter-over-quarter from $44.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Revenue (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Revenue history runs 17 years deep, the most recent figure standing at $37.2 million for Q1 2026.
- In Q1 2026, Revenue changed 0.07% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $160.0 million (up 5.04% YoY), while the FY2025 annual figure was $160.0 million, up 3.89% from the prior year.
- Revenue for Q1 2026 stood at $37.2 million, down from $44.6 million in the prior quarter.
- The five-year high for Revenue was $58.4 million in Q4 2023, with the low at $27.4 million in Q4 2022.
- The 5-year median for Revenue is $38.8 million (2024), against an average of $40.0 million.
- The sharpest annual moves came in 2023 and 2024: Revenue surged 113.35% in 2023, then slumped 32.79% in 2024.
- Pacific Biosciences Of California's Revenue stood at $27.4 million in 2022, then jumped by 113.35% to $58.4 million in 2023, then plunged by 32.79% to $39.2 million in 2024, then increased by 13.82% to $44.6 million in 2025, then slipped by 16.73% to $37.2 million in 2026.
- Business Quant data shows PACB's Revenue at $37.2 million in Q1 2026, $44.6 million in Q4 2025, and $38.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 6.59 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 5.44 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 1.74 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 1.31 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 5.30 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 9.61 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Pacific Biosciences Of California | 386.77 Mn | 149.89 Mn | 12.64 Mn | 39.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.01 Mn |
| Mar 31, 2026 | 37.18 Mn |
| Dec 31, 2025 | 44.65 Mn |
| Sep 30, 2025 | 38.44 Mn |
| Jun 30, 2025 | 39.77 Mn |
| Mar 31, 2025 | 37.15 Mn |
| Dec 31, 2024 | 39.22 Mn |
| Sep 30, 2024 | 39.97 Mn |
| Jun 30, 2024 | 36.01 Mn |
| Mar 31, 2024 | 38.81 Mn |
| Dec 31, 2023 | 58.36 Mn |
| Sep 30, 2023 | 55.69 Mn |
| Jun 30, 2023 | 47.57 Mn |
| Mar 31, 2023 | 38.90 Mn |
| Dec 31, 2022 | 27.35 Mn |
| Sep 30, 2022 | 32.31 Mn |
| Jun 30, 2022 | 35.47 Mn |
| Mar 31, 2022 | 33.17 Mn |
| Dec 31, 2021 | 36.02 Mn |
| Jun 30, 2021 | 30.61 Mn |